# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Alpha Thalassemia
- **MONDO ID:**  (if available)
- **Category:** Mendelian

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Alpha Thalassemia**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-02-15T21:57:01.162714

1. zahed2023effectiveutilizationof pages 64-67
2. kuo2023pyruvatekinaseactivators pages 1-2
3. wongkhammul2024erythropoiesisandgene pages 1-2
4. chaemsaithong2023placentaderivedextracellularvesicles pages 1-2
5. wongkhammul2024erythropoiesisandgene pages 2-4
6. du2024screeningforthalassemia pages 1-2
7. xia2024aparticularfocus pages 1-2
8. traisrisilp2024thalassemiascreeningby pages 1-2
9. chaemsaithong2023placentaderivedextracellularvesicles pages 4-5
10. li2024hotspotsandstatus pages 13-14
11. sadiq2024thalassemiapathophysiologydiagnosis pages 4-6
12. sadiq2024thalassemiapathophysiologydiagnosis pages 6-7
13. luewan2024fetalhemodynamicchanges pages 4-6
14. luewan2024fetalhemodynamicchanges pages 1-2
15. jatavan2023comparisonsofserum pages 1-2
16. jatavan2023comparisonsofserum pages 4-5
17. isaiah2024prevalenceofthalassemia pages 3-4
18. kuo2023pyruvatekinaseactivators pages 3-4
19. kuo2023pyruvatekinaseactivators pages 4-6
20. https://doi.org/10.3390/ijms24065658
21. https://doi.org/10.3389/fmed.2022.1015306
22. https://doi.org/10.1182/hematology.2023000468
23. https://doi.org/10.1186/s12884-023-06232-x
24. https://doi.org/10.3389/fgene.2024.1356068
25. https://doi.org/10.3390/ijms25063400
26. https://doi.org/10.1371/journal.pone.0306043
27. https://doi.org/10.3390/ijms252011246
28. https://doi.org/10.3389/fgene.2024.1422462
29. https://doi.org/10.1177/1753495x231207676
30. https://doi.org/10.3390/thalassrep14040010,
31. https://doi.org/10.3390/ijms24065658,
32. https://doi.org/10.1186/s12884-023-06232-x,
33. https://doi.org/10.1182/hematology.2023000468,
34. https://doi.org/10.3390/ijms252011246,
35. https://doi.org/10.3389/fmed.2022.1015306,
36. https://doi.org/10.18535/cmhrj.v4i2.325,
37. https://doi.org/10.3390/ijms25063400,
38. https://doi.org/10.1371/journal.pone.0306043,
39. https://doi.org/10.3389/fgene.2024.1356068,
40. https://doi.org/10.3389/fgene.2024.1422462,
41. https://doi.org/10.1177/1753495x231207676,
42. https://doi.org/10.3389/fped.2024.1467760,